Highfield Diagnostics is a recent spinout from the University of Southampton in the United Kingdom. Over the last three years, the Highfield Diagnostics team within the University has developed a laser-based technology that enables the creation of shaped flow paths with advanced flow-control in lateral flow tests. Highfield Diagnostics mission is to use this platform technology to provide breakthrough solutions for several issues currently encountered by lateral flow manufacturers. By enabling newer capabilities such as multiplexed and semi-quantitative testing currently unavailable with lateral flow tests, Highfield Diagnostics aim is to bring a change to lateral-flow test enabled rapid point-of-care diagnostics.
Within the domain of rapid testing, Highfield Diagnostics is developing the following lateral flow products:
1. A multiplexed test that presents a population-screening pathway for Tuberculosis testing.
2. A multiplexed test for human neglected tropical disease, with a veterinary test to follow soon.
A semi-quantitative test for inflammation markers, CRP and SAA1 for applications in Dementia.